GPT and hepatocellular carcinoma: When PIVKA-II was combined with the γ-GT/ALT ratio and AFP for diagnosis of early-stage HCC, there was almost no difference between AUROCS for combined and single diagnosis (0.857 versus 0.851, respectively; P = 0.858; Fig. 2A,B).